bisbenzimidazole has been researched along with Chondrosarcoma in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Chondrosarcoma: A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, GJ | 1 |
| Ferrara, JA | 1 |
1 other study available for bisbenzimidazole and Chondrosarcoma
| Article | Year |
|---|---|
Identification of normal or neoplastic murine mesenchymal cells in chimeric tissues or heterotransplants.
Topics: Animals; Bisbenzimidazole; Carcinoma 256, Walker; Cell Nucleus; Chimera; Chondrosarcoma; Mesoderm; M | 1988 |